Pulmonary embolism landmark trials: Difference between revisions

Jump to navigation Jump to search
Line 5: Line 5:


===Trials assessing the diagnosis===
===Trials assessing the diagnosis===
1. '''PIOPED (Prospective Investigation in Pulmonary Embolism Diagnosis)''' (1989).
1. '''PIOPED (Prospective Investigation in Pulmonary Embolism Diagnosis)''' (1989).<ref name="pmid2332918">{{cite journal |author= |title=Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). The PIOPED Investigators |journal=JAMA |volume=263 |issue=20 |pages=2753–9 |year=1990 |pmid=2332918 |doi= |url= |accessdate=2012-01-10}}</ref>
* '''Purpose :''' To evaluate the sensitivity and specificity of two major, widely used technologies, radionuclear imaging (ventilation-perfusion scanning) and pulmonary angiography, for the diagnosis of pulmonary embolism.
* '''Purpose :''' To evaluate the sensitivity and specificity of two major, widely used technologies, radionuclear imaging (ventilation-perfusion scanning) and pulmonary angiography, for the diagnosis of pulmonary embolism.



Revision as of 15:25, 10 January 2012

Pulmonary Embolism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary Embolism from other Diseases

Epidemiology and Demographics

Risk Factors

Triggers

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

Assessment of Clinical Probability and Risk Scores

Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores

History and Symptoms

Physical Examination

Laboratory Findings

Arterial Blood Gas Analysis

D-dimer

Biomarkers

Electrocardiogram

Chest X Ray

Ventilation/Perfusion Scan

Echocardiography

Compression Ultrasonography

CT

MRI

Treatment

Treatment approach

Medical Therapy

IVC Filter

Pulmonary Embolectomy

Pulmonary Thromboendarterectomy

Discharge Care and Long Term Treatment

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Follow-Up

Support group

Special Scenario

Pregnancy

Cancer

Trials

Landmark Trials

Case Studies

Case #1

Pulmonary embolism landmark trials On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary embolism landmark trials

CDC on Pulmonary embolism landmark trials

Pulmonary embolism landmark trials in the news

Blogs on Pulmonary embolism landmark trials

Directions to Hospitals Treating Pulmonary embolism landmark trials

Risk calculators and risk factors for Pulmonary embolism landmark trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Ujjwal Rastogi, MBBS [2]

Landmark Clinical Trials

Trials assessing the diagnosis

1. PIOPED (Prospective Investigation in Pulmonary Embolism Diagnosis) (1989).[1]

  • Purpose : To evaluate the sensitivity and specificity of two major, widely used technologies, radionuclear imaging (ventilation-perfusion scanning) and pulmonary angiography, for the diagnosis of pulmonary embolism.

References

  1. "Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). The PIOPED Investigators". JAMA. 263 (20): 2753–9. 1990. PMID 2332918. |access-date= requires |url= (help)

Template:WH Template:WS